Biotechnological Applications in Medicine 🤖
Why this matters
Recombinant-DNA techniques let us mass-produce safe, human-identical drugs that sidestep allergy problems seen with animal products. About 30 recombinant medicines are approved worldwide, and 12 are already sold in India.👏 :contentReference[oaicite:11]{index=11}
1. Genetically Engineered Insulin 🩸
- Human insulin contains two short chains—A and B—joined by disulfide bridges \(S\!-\!S\). :contentReference[oaicite:12]{index=12}
- Natural production begins as pro-insulin, a longer form that loses its C-peptide to become active. :contentReference[oaicite:13]{index=13}
- Before biotech, insulin from cattle & pigs often triggered allergic reactions.
- In 1983, Eli Lilly built separate DNA codes for chains A and B, slipped them into E. coli, harvested each chain, then reunited them to give fully functional human insulin. :contentReference[oaicite:14]{index=14}
- Result: a limitless, allergy-free insulin supply for people with adult-onset diabetes.
2. Gene Therapy – Fix the Gene, Fix the Problem 🧬
Gene therapy introduces a working gene into cells (or even an embryo) to replace a faulty one. :contentReference[oaicite:15]{index=15}
ADA-deficiency success story 🎉
- First trial (1990) helped a 4-year-old lacking adenosine deaminase (ADA), an enzyme vital for immunity. :contentReference[oaicite:16]{index=16}
- Doctors collected her lymphocytes, inserted functional
ADA cDNA
via a retroviral vector, and infused the cells back. - Because lymphocytes don’t live forever, periodic top-ups are needed—unless the gene is added at the embryo stage, which could offer a permanent cure. :contentReference[oaicite:17]{index=17}
3. Molecular Diagnosis 🔬
Spot disease long before symptoms show!
- PCR (Polymerase Chain Reaction) multiplies trace DNA/RNA from pathogens—ideal for early HIV tests, cancer-gene checks, and many other disorders. :contentReference[oaicite:18]{index=18}
- Probe Hybridisation: a radioactive single-stranded probe binds only to its perfect DNA match. A missing signal = mutation present. :contentReference[oaicite:19]{index=19}
- ELISA: relies on antigen-antibody “lock-and-key” binding to catch either the germ’s proteins or the host’s antibodies against them. :contentReference[oaicite:20]{index=20}
Big-picture benefits 🌐
- No unwanted immune reactions—products are human-identical.
- Scalable factory-like production keeps costs down and supply steady.
Important Concepts for NEET 📚
- Structure & recombinant manufacture of human insulin.
- Steps and rationale of ADA gene therapy.
- PCR as a sensitive early-diagnosis tool.
- Principle and uses of ELISA.
- Why recombinant drugs trump animal-derived versions.